Synergy of CD95 ligand and teniposide: No role of cleavable complex formation and enhanced CD95 expression

Author： Winter S.   Roth W.   Dichgans J.   Weller M.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.341, Iss.2, 1998-01, pp. : 323-328

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD95 Signaling in Cancer Treatment

By  

Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. : 2809-2818

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy primes malignant glioma cells for CD95 ligand-induced apoptosis up-stream of caspase 3 activation

By Hueber A.   Winter S.   Weller M.  

European Journal of Pharmacology, Vol. 352, Iss. 1, 1998-07 ,pp. : 111-115

Elsevier

Access to resources Recommend Favorite

The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review

By  

Current Cancer Drug Targets, Vol. 14, Iss. 7, 2014-09 ,pp. : 610-620

Bentham Science Publishers

Access to resources Recommend Favorite

Characterization of the P95 cellular component phosphorylated on tyrosine after activation of the C3d/Epstein-Barr virus receptor (gp140, CR2, CD21) on human B lymphocytes

By Barel M.   Frade R.  

Immunopharmacology, Vol. 49, Iss. 1, 2000-08 ,pp. : 50-50

Elsevier

Access to resources Recommend Favorite

Acute Rejection Correlates with Expression of Major Histocompatibility Complex Class I Antigens on Peripheral Blood CD3+CD8+ T-Lymphocytes following Skin Transplantation in Mice

By Zhou YX   Zhao SM   Lu N   Yang XJ   Zhang Y   Li YJ   Zou X  

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 480-487

Field House Publishing

Access to resources Recommend Favorite